They have shown that changes in E-cadherin/β-catenin expression patterns are common in lung neuroendocrine tumors, with either subcellular redistribution and/or down-regulation and that the subcellular compartmentalization of β-catenin is profoundly altered in LCNEC. Here, CDH1 is linked to large cell neuroendocrine carcinoma.